Key result
Cardiovascular foundation models show promise across applications but face major barriers to routine clinical deployment.
Why the study?
Cardiovascular disease remains the leading global cause of mortality, while large-scale foundation models are increasingly studied for diagnosis, risk prediction, workflow support, and treatment personalization.
Foundation models offer scalable, multimodal AI capabilities for cardiovascular medicine, but require rigorous external validation and prospective clinical testing before routine deployment.
Hypothesis-generating for cardiovascular foundation models; prospective trials needed before clinical adoption.
Background Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, accounting for more than 17 million deaths annually. Foundation models (FMs) are large-scale artificial intelligence systems pre-trained on broad datasets and increasingly studied for cardiovascular diagnosis, risk prediction, workflow support, and treatment personalization. Methods This narrative review synthesized FMs applied to cardiovascular medicine, including text-based, image-based, multimodal, and time-series models. The review examined model architectures, training strategies, performance metrics, clinical applications, implementation challenges, and evidence maturity using a three-tier framework. Results Cardiovascular FMs show promising but unevenly validated capabilities across multiple applications. ECG-based models such as ECGFounder have reported strong external validation performance for rhythm and conduction diagnoses, whereas imaging models such as Echo-Vision-FM supports cardiac function assessment and pathology classification. Multimodal models, including CardioGPT and EchoCLIP, illustrate the potential value of integrating clinical text, imaging, and physiological signals, although several remain at a conceptual or proof-of-concept stage. Conclusions FMs may become important tools in cardiovascular medicine by supporting earlier diagnosis, risk stratification, and clinical decision-making. However, the current evidence base remains heterogeneous, and major barriers persist, including limited interpretability, underrepresentation of diverse populations in training data, regulatory uncertainty, computational demands, and workflow-integration challenges. Inclusive data development, transparent reporting, external validation, prospective clinical evaluation, and interdisciplinary implementation research are needed before these models can be deployed safely and equitably in routine cardiovascular care.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2026) conducted a review in Cardiovascular disease. Foundation models was evaluated. Cardiovascular foundation models show promising capabilities across multiple applications, but the current evidence base remains heterogeneous with major barriers to routine clinical deployment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: